| |
| |
|
| Insider
Information: |
Mcdowell Caryn Gordon |
| Relationship: |
Chief Legal & Adm. Off... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
178,501 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,182,159 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
178,501 |
|
|
| Total
Value |
$2,182,159 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytokinetics Inc |
CYTK |
GC & Chief Compliance ... |
2018-02-28 |
32,548 |
|
0 |
Premium* |
|
|
Revance Therapeutics, Inc. |
RVNC |
SVP, GC & Secretary |
2020-02-15 |
23,453 |
2018-05-01 |
0 |
Premium* |
|
|
Cortexyme, Inc. |
CRTX |
Chief Legal & Adm. Off... |
2022-06-06 |
122,500 |
2022-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance OfficerO |
• – – |
2016-05-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,810 |
|
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2017-09-06 |
4 |
AS |
$15.00 |
$1,500 |
D/D |
(100) |
18,369 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2019-12-31 |
4 |
A |
$10.82 |
$4,133 |
D/D |
382 |
24,317 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2018-12-31 |
4 |
A |
$17.11 |
$13,996 |
D/D |
818 |
16,818 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2020-02-15 |
4 |
D |
$25.33 |
$21,885 |
D/D |
(864) |
23,453 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2019-06-28 |
4 |
A |
$11.02 |
$11,025 |
D/D |
1,000 |
23,935 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2017-11-02 |
4 |
OE |
$6.37 |
$8,850 |
D/D |
1,355 |
15,000 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2019-06-15 |
4 |
D |
$10.86 |
$15,019 |
D/D |
(1,383) |
22,935 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2018-02-28 |
4 |
D |
$7.75 |
$19,003 |
D/D |
(2,452) |
32,548 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2018-01-16 |
4 |
AS |
$9.00 |
$24,381 |
D/D |
(2,709) |
15,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2018-01-16 |
4 |
OE |
$6.37 |
$17,694 |
D/D |
2,709 |
15,625 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2017-11-02 |
4 |
AS |
$12.90 |
$55,134 |
D/D |
(4,260) |
14,375 |
0 |
- |
|
| CRTX |
Cortexyme, Inc. |
Chief Legal & Adm. Officer |
• – – |
2022-06-06 |
4 |
D |
$2.86 |
$19,183 |
D/D |
(6,700) |
133,300 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
24,318 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2017-08-08 |
4 |
OE |
$6.37 |
$61,995 |
D/D |
9,538 |
28,917 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2017-09-06 |
4 |
AS |
$14.10 |
$147,864 |
D/D |
(10,131) |
18,469 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2017-09-06 |
4 |
OE |
$6.37 |
$66,521 |
D/D |
10,231 |
28,200 |
0 |
- |
|
| CRTX |
Cortexyme, Inc. |
Chief Legal & Adm. Officer |
• – – |
2022-06-06 |
4 |
AS |
$2.86 |
$30,923 |
D/D |
(10,800) |
122,500 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2017-08-08 |
4 |
AS |
$12.35 |
$141,467 |
D/D |
(11,348) |
18,369 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2017-10-06 |
4 |
OE |
$6.37 |
$75,352 |
D/D |
11,583 |
27,452 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2017-10-06 |
4 |
AS |
$15.20 |
$204,162 |
D/D |
(13,181) |
16,771 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2017-02-28 |
4 |
A |
$0.00 |
$15 |
D/D |
15,000 |
18,581 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
SVP, GC & Secretary |
• – – |
2018-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
16,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
GC & Chief Compliance Officer |
• – – |
2018-02-27 |
4 |
A |
$0.00 |
$20 |
D/D |
20,000 |
35,000 |
0 |
- |
|
| CRTX |
Cortexyme, Inc. |
Chief Legal & Adm. Officer |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
140,000 |
140,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
